Thrombophilia testing

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 6, 2003, Pages 1311-1312

  Martinelli, I ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; MASS SCREENING; NOTE; RISK FACTOR; THROMBOPHILIA; THROMBOSIS;

HUMANS; MASS SCREENING; RISK FACTORS; THROMBOPHILIA; THROMBOSIS;

EID: 2142754397     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00326.x     Document Type: Letter

References (12)

1. Machin SJ. Pros and cons of thrombophilia testing. Cons. J Thromb Haemost 2003; 1: 412-3.
2. Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Oral contraceptives, hormone replacement therapy and thrombosis. Thromb Haemost 2001; 86: 112-23.
3. Ferrari E, Chevallier T, Chapelier A, Baudouy M. Travel as a risk factor for venous thromboembolic disease. A case-control study. Chest 1999; 115: 440-4.
4. Kraaijenhagen RA, Haverkamp D, Koopman MMW, Prandoni P, Pio-vella F, Biiller HR. Travel and risk of venous thrombosis. Lancet 2000; 356: 1492.
5. Hirsh J, O'Donnell M. Venous thromboembolism after long flights: are airlines to blame? Lancet 2001; 357: 1461-2.
6. Sarasin FP, Bounameaux H. Decision analysis model of prolonged oral anticoagulant treatment in factor V Leiden carriers with first episode of deep vein thrombosis. BMJ 1998; 316: 95-9.
7. Rosendaal FR. Risk factors for venous thrombotic disease. Thromb Haemost 1999; 82: 610-9.
8. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients with homozygous factor V Leiden (activated protein C resistance). Blood 1995; 85: 1504-8.
9. Samama MM, Trossaert M, Horellou MH, Elalamy I, Conard J, Deschamps A. Risk of thrombosis in patients homozygous for factor V Leiden. Blood 1995; 86: 4700-2.
10. Emmerich J, Rosendaal FR, Cattaneo M, Margaglione M, De Stefano V, Cumming T, Arruda V, Hillarp A, Reny JL. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism. Thromb Haemost 2001; 86: 809-16
11. Keenan C, Livingstone WJ, White B, Mynett-Johnson L, Cusack S, Lawler M, Smith OP. Prevalence of the prothrombin G20210A mutation in the Irish populations: use of a novel polymerase chain reaction approach. Blood Coagul Fibrinolysis 2000; 11: 669-72.
12. Martinelli I. Pros and cons of thrombophilia testing. Pros. J Thromb Haemost 2003; 1: 410-11.